Prognostic Parameters and Detection of Cardiac Amyloidosis with Hybrid 18F-Florbetaben-PET/MRI: An exploratory observational Study

IF 2.7 4区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of Nuclear Cardiology Pub Date : 2025-08-01 DOI:10.1016/j.nuclcard.2025.102375

David Kersting MD PhD , Lukas Kessler MD , Wibke Tonscheidt MD , Kai Nassenstein MD , Stephan Settelmeier MD , Alexander Carpinteiro MD , Tim Hagenacker MD , Lale Umutlu MD , Christoph Kleinschnitz MD , Simon Wernhart MD PhD , Lars Michel MD , Michal K. Chodyla MD , Benedikt M. Schaarschmidt MD , Thomas W. Schlosser MD , Wolfgang Fendler MD , Francesco Barbato MD , Maria Papathanasiou MD , Christoph Rischpler MD PhD , Ken Herrmann MD , Tienush Rassaf MD

引用次数: 0

查看原文本刊更多论文

18F-Florbetaben-PET/MRI杂交预测参数和检测心脏淀粉样变性：一项探索性观察研究

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Nuclear Cardiology 医学-核医学

CiteScore

5.30

自引率

20.80%

发文量

249

审稿时长

4-8 weeks

期刊介绍： Journal of Nuclear Cardiology is the only journal in the world devoted to this dynamic and growing subspecialty. Physicians and technologists value the Journal not only for its peer-reviewed articles, but also for its timely discussions about the current and future role of nuclear cardiology. Original articles address all aspects of nuclear cardiology, including interpretation, diagnosis, imaging equipment, and use of radiopharmaceuticals. As the official publication of the American Society of Nuclear Cardiology, the Journal also brings readers the latest information emerging from the Society''s task forces and publishes guidelines and position papers as they are adopted.